Expanded Access for Idelalisib in Combination With Rituximab in Chronic Lymphocytic Leukemia
Clinical trial NCT02136511 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT02136511
- Sponsor
- Gilead Sciences
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.